Castellani: Rules show PhRMA's commitment to responsible data sharing

07/29/2013 | The Scientist online · Xconomy · PharmaTimes (U.K.)

The pharmaceutical industry's new transparency measures should go further, according to the AllTrials campaign. The initiative clearly shows PhRMA members' lasting commitment to the responsible sharing of clinical trial information, PhRMA President and CEO John J. Castellani said. In Xconomy, Luke Timmerman writes that the commitment doesn't go far enough and that pharma could embrace the openness of the Internet era, because greater openness and Big Data hold great promise.

View Full Article in:

The Scientist online · Xconomy · PharmaTimes (U.K.)